Investigators sought to determine whether lipoprotein(a) and oxidized phospholipids on apolipoprotein B-100 levels can affect disease activity, disease progression, and clinical events in patients with aortic stenosis.
Early aortic valve replacement (AVR) may improve survival in patients with severe, asymptomatic aortic stenosis.
The severity of lung disease in preterm infants with bronchopulmonary dysplasia and pulmonary hypertension undergoing cardiac catheterization did not correlate with mortality.
Data show 47 percent reduction in risk for rehospitalization for HF symptoms with device implantation
Lipoprotein(a) levels should be measured in mild to moderate calcific aortic valve stenosis to improve patient risk stratification.
A new consensus statement provides updated guidelines for antithrombotic therapy in patients with atrial fibrillation associated with valvular heart disease.
The guidelines modify 2014 recommendations relating to aortic valve replacement and transcatheter aortic valve replacement procedures.
